Introduction
============

Skin photoaging refers to the aging process resulting from exposure to ultraviolet (UV) light ([@b1-mmr-15-01-0111]), characterized by roughening and thickening of the skin, increased flaccidity, coarse wrinkles, local pigmentation, or telangiectasia ([@b2-mmr-15-01-0111]--[@b4-mmr-15-01-0111]). It may also lead to benign or malignant tumors, including sunlight keratosis, squamous cell carcinoma and malignant melanoma ([@b5-mmr-15-01-0111]).

Photoaging has a complex mechanism. Altered levels of reactive oxygen species (ROS), extracellular matrix components, matrix metalloproteinases and cytokines are linked to photoaging, particularly increased ROS levels ([@b6-mmr-15-01-0111]). Upon receiving UV energy, intracellular chromophores interact with oxygen molecules, creating ROS that cause direct cell damage when levels increase above a certain threshold ([@b7-mmr-15-01-0111]--[@b9-mmr-15-01-0111]). Elevated ROS levels also activate a series of signaling pathways through expression of signaling molecules including extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinase (JNK), and p38 in the mitogen-activated protein kinase (MAPK) pathway. This results in increased matrix metalloproteinase (MMP) expression, and a reduction in collagen protein synthesis and secretion ([@b10-mmr-15-01-0111],[@b11-mmr-15-01-0111]). Type I collagens are an important component of the extracellular matrix that are degraded by MMP-1 ([@b12-mmr-15-01-0111]). During the photoaging process MMP-1 is overexpressed, resulting in collagen degradation and disintegration ([@b12-mmr-15-01-0111]--[@b16-mmr-15-01-0111]).

Physically covering skin is known to minimize UV damage, but antioxidant and antiinflammatory agents are also increasingly being used ([@b17-mmr-15-01-0111],[@b18-mmr-15-01-0111]). Current clinical treatments to prevent and delay photoaging rely on photo-dynamic therapy ([@b19-mmr-15-01-0111]) and antioxidants including polyphenols and β-carotene ([@b20-mmr-15-01-0111]). Previous studies have demonstrated the positive effects of herbal extracts in preventing skin photoaging: Sun *et al* ([@b21-mmr-15-01-0111]) revealed that wild chrysanthemum extract downregulates ROS levels within HaCat cells and so reduces MMP-2 and MMP-9 expression by inhibiting UV-induced ERK1/2 and p38 phosphorylation to prevent UVB-related acute skin damage and photoaging. Lee *et al* ([@b22-mmr-15-01-0111]) demonstrated that macelignan, an effective antioxidant found in the nutmeg, *Myristica fragans*, downregulates MMP-1 expression by reducing UV exposure-related ROS elevation and MAPK phosphorylation. In addition, it increases type I collagen expression by activating transforming growth factor β (TGF-β)/SMAD signaling to effectively prevent and treat skin photoaging.

The fungus *Ganoderma lucidum* is a famous herbal medicine in China, having featured in traditional Chinese medicine for \>1,000 years ([@b23-mmr-15-01-0111]--[@b25-mmr-15-01-0111]). *G. lucidum* polysaccharides (GL-PS) display regulatory abilities toward the immune system, resulting in antitumor and antioxidation effects ([@b26-mmr-15-01-0111]--[@b28-mmr-15-01-0111]). GL-PS has been demonstrated to protect murine skeletal muscles from oxidative stress following exhaustive exercise ([@b29-mmr-15-01-0111]). GL-PS also regulates gene expression in aging skin cells and induces cytokine secretion, suggesting potential anti-aging effects ([@b29-mmr-15-01-0111]). Considering the close relation of photoaging to unbalanced oxidative stress and the antioxidative effect of GL-PS, the present study hypothesized that GL-PS confers protection from photoaging on skin cells.

The present study, to the best of our knowledge, is the first to demonstrate that GL-PS protects fibroblasts from UVB-induced photoaging. The mechanism underlying this may be the reduction of UVB-induced ROS levels, inhibiting the MAPK signal pathway and therefore MMP-1 expression, while promoting type I collagen expression. This suggests that GL-PS may have clinical potential in treating photoaging.

Materials and methods
=====================

### Materials

Dulbecco\'s modified Eagle\'s medium (DMEM) was obtained from Gibco; Thermo Fisher Scientific, Inc. (Waltham, MA, USA), fetal bovine serum (FBS) from HyClone; GE Healthcare Life Sciences (Logan, UT, USA), 98% purity GL-PS from Shaanxi Ciyuan Biotech Co., Ltd. (Xi\'an, China), senescence-associated β-galactosidase staining (SA-β-gal) kit from Beyotime Institute of Biotechnology (Haimen, China), ROS detection kit from Nanjing KeyGen Biotech Co., Ltd. (Nanjing, China), MMP-1 ELISA detection kit (cat. no. EK0458) from Boster Systems, Inc. (Wuhan, China), C-telopeptides of type I collagen (CICP) ELISA detection kit (cat. no. XY-67851Hu) from Shanghai Xin Yu Biotech Co., Ltd (Shanghai, China) and UVB radiation apparatus (SS-07) from Shanghai SIGMA High Tech Co., Ltd. (Shanghai, China).

### Fibroblast isolation and culture

Samples were obtained from the donated foreskin of a healthy man (age, 18 years) following circumcision, with informed consent. The foreskin was soaked in iodine for 15 min and subsequently rinsed with PBS. Subcutaneous tissues were removed, and the remaining tissue was cut into small pieces (\<5 mm). Trypsin was applied to isolate fibroblasts, and all cells were subsequently collected, washed and cultured in DMEM containing 10% FBS. When cells were 80--90% confluent, they were passaged at a ratio of 1:3. Exponential growth phase cells from passages 4--8 were used for subsequent experiments.

### Groups, treatment and UVB exposure

Cells were either exposed to UVB, exposed to UVB and treated with GL-PS, or non-exposed and untreated. GL-PS 1 mg/ml was reconstituted in 1X PBS and was stored at 4°C. Solutions of different GL-PS concentration were made by diluting in FBS-free DMEM prior to use. All cells were cultured in FBS-free media for 24 h prior to UVB exposure. Immediately prior to exposure, all media was vacuumed, and cell layers were rinsed 3 times with sterile PBS. Following UVB exposure, matched media was added immediately.

### Cell viability assay (MTT assay)

Cells were seeded in a 96-well plate (1×10^4^ cells/well), with a volume of 200 µl per well. Following attachment to the dish, cells were starved with FBS-free media for 24 h. All media was vacuumed prior to UVB exposure. When exposure was completed, cells were cultured in serum-free media for 24 h, with the specified concentrations of GL-PS where appropriate. MTT was then added (20 µl, 5 mg/ml) and the cells cultured for a further 4 h. Supernatant was then discarded and 150 µl dimethyl sulfoxide added. Absorbances were measured at 490 nm with a microplate reader.

### Detection of aging cells using an SA-β-gal kit

Following UVB exposure and treatment with the specified concentrations of GL-PS, an SA-β-gal kit was used to stain aging cells according to the manufacturer\'s instructions. Samples were checked using a light microscope under ×200 magnification. For each sample, \>200 cells from 15 randomly selected fields were checked to calculate the percentage of aging cells (blue stained cell number/total cell number ×100).

### Measurement of intracellular ROS by flow cytometry

Cells were prepared according to the manufacturer\'s instructions for use with the ROS detection kit 24 h after UVB exposure and treatment with GL-PS. Images were captured using a fluorescence microscope, and fluorescence intensity was detected by flow cytometry (FACSCalibur; BD Biosciences, Franklin Lakes, NJ, USA) with BD CellQuest Pro software (version 6.0; BD Biosciences).

### Detection of MMP-1 and CICP expression by ELISA

Cell supernatants were collected 24 h following UVB exposure and treatment with GL-PS, and centrifuged at 1,000 × *g* for 10 min. ELISA kits were used to detect MMP-1 and CICP concentrations according to the manufacturer\'s instructions. CICP content was used to represent the Type I collagen content.

### Statistical analysis

All experiments were repeated independently at least in triplicate. Experimental data were analyzed with SPSS 19.0 (IBM SPSS, Armonk, NY, USA). Unpaired Students *t*-tests were applied to analyze differences between groups. All data are presented as the mean + standard deviation. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Fibroblast viability is reduced dose-dependently by UVB exposure

Fibroblasts were exposed to a range of UVB doses (0, 20, 40, 60, 80, 120, 160 and 200 mJ/cm^2^), then cellular density and changes in condition were observed, and cell viability assessed by MTT assay. Following UVB exposure, fibroblast density decreased in a dose-dependent manner ([Fig. 1A](#f1-mmr-15-01-0111){ref-type="fig"}). In addition, when UVB dosage exceeded 80 mJ/cm^2^, a noticeable increase in dead cells was observed ([Fig. 1A](#f1-mmr-15-01-0111){ref-type="fig"}). A dose-dependent decrease in cellular viability following UVB exposure was also demonstrated ([Fig. 1B](#f1-mmr-15-01-0111){ref-type="fig"}). The lowest dose to demonstrate significantly reduced cell viability compared with non-exposed cells was 60 mJ/cm^2^ (−27.71%; P=0.0083 [Fig. 1B](#f1-mmr-15-01-0111){ref-type="fig"}), therefore this dose was used for subsequent experiments.

### GL-PS confers protection against UVB-induced cell death to fibroblasts

GL-PS toxicity towards fibroblasts was examined by analysis of cell viability following treatment with different GL-PS concentrations. Compared with untreated cells, increased cell viability was observed in groups treated with 20, 40 and 80 µg/ml GL-PS (P=0.0069, P=0.0074 and P=0.0037, respectively; [Fig. 2A](#f2-mmr-15-01-0111){ref-type="fig"}), but cells treated with 160 µg/ml GL-PS demonstrated no significant difference in viability compared with untreated control ([Fig. 2A](#f2-mmr-15-01-0111){ref-type="fig"}). Therefore, GL-PS promotes fibroblast viability, but only within a certain range.

Following exposure to 60 mJ/cm^2^ UVB, cells treated with 10, 20 and 40 µg/ml GL-PS demonstrated increased viability compared with untreated cells (P=0.0025, P=0.0096 and P=0.0016, respectively; [Fig. 2B](#f2-mmr-15-01-0111){ref-type="fig"}), suggesting that GL-PS confers protective effects towards fibroblasts from UVB damage.

### GL-PS inhibits UVB-induced fibroblast aging

Aging cells were peri-nuclearly stained blue, using the SA-β-gal kit ([Fig. 3A](#f3-mmr-15-01-0111){ref-type="fig"}). The percentage of stained cells was 25.95% in the UVB non-exposed/GL-PS untreated group compared with 63.53% in the UVB exposed/GL-PS untreated group (P=0.0001; [Fig. 3B](#f3-mmr-15-01-0111){ref-type="fig"}). No significant difference in staining was observed in UVB exposed cells treated with 10 (57.00%) and 20 µg/ml (58.98%) GL-PS compared with UVB exposed/GL-PS untreated cells ([Fig. 3B](#f3-mmr-15-01-0111){ref-type="fig"}). However, for UVB exposed cells treated with 40 µg/ml GL-PS, there was a statistically significant decrease in staining compared with UVB exposed/GL-PS untreated cells, with 50.96% of cells stained (P=0.0322; [Fig. 3B](#f3-mmr-15-01-0111){ref-type="fig"}).

### GL-PS inhibits UVB-induced protein expression of MMP-1 in fibroblasts, and increases protein expression of CICP

MMP-1 protein expression in fibroblasts was significantly increased following UVB exposure compared with non-exposed cells (P=0.0097; [Fig. 4A](#f4-mmr-15-01-0111){ref-type="fig"}). UVB exposed cells expressed significantly lower levels of MMP-1 protein following treatment with 10, 20 and 40 µg/ml GL-PS compared with untreated cells (P=0.0043, P=0.0007 and P=0.0090, respectively; [Fig. 4A](#f4-mmr-15-01-0111){ref-type="fig"}). CICP protein expression levels decreased in fibroblasts following UVB exposure compared with non-exposed cells (P=0.0362 [Fig. 4B](#f4-mmr-15-01-0111){ref-type="fig"}), but CICP protein expression levels increased dose-dependently in UVB exposed cells following GL-PS-treatment, with a statistically significant difference observed in the 40 µg/ml treatment group compared with untreated cells (P=0.0074; [Fig. 4B](#f4-mmr-15-01-0111){ref-type="fig"}).

### GL-PS inhibits UVB-induced ROS in fibroblasts

UVB exposed cells exhibited increased fluorescence compared with non-exposed control cells, indicating increased ROS production (P=0.0032; 2.3 fold difference; [Fig. 5A](#f5-mmr-15-01-0111){ref-type="fig"}). Fluorescence decreased in UVB exposed cells as GL-PS concentration increased ([Fig. 5A](#f5-mmr-15-01-0111){ref-type="fig"}). The flow cytometry results demonstrated a similar trend, with a non-significant decrease in ROS in UVB exposed cells treated with 10 µg/ml GL-PS compared with UVB exposed/GL-PS untreated cells (P=0.313; [Fig. 5B](#f5-mmr-15-01-0111){ref-type="fig"}) and significant decreases in UVB exposed cells treated with 20 and 40 µg/ml GL-PS compared with UVB exposed/GL-PS untreated cells (P=0.0406 and P=0.0172, respectively; [Fig. 5B](#f5-mmr-15-01-0111){ref-type="fig"}). This suggests that above a threshold concentration, GL-PS reduces UVB-induced ROS production.

Discussion
==========

*Ganoderma*, a popular traditional drug in Asia, is a member of the Polyporaceae family and is endemic to tropical areas ([@b24-mmr-15-01-0111]). Previous research had revealed multiple pharmaceutical properties of *Ganoderma*, including antitumor effects ([@b30-mmr-15-01-0111]), immune regulation ([@b31-mmr-15-01-0111]), antioxidative effects ([@b32-mmr-15-01-0111]), hepatoprotective effect against CCl4-induced liver injury ([@b33-mmr-15-01-0111]), and the ability to lower blood sugar ([@b34-mmr-15-01-0111]). A major active ingredient in *Ganoderma* is GL-PS, which is formed from three single strands of monosaccharide chains, including glucose, galactose, mannose and arabinose, which form a helical three dimensional configuration ([@b35-mmr-15-01-0111]). In traditional Chinese medicine, *Ganoderma* is used as an anti-aging drug, and modern research has previously demonstrated the anti-aging effects of *Ganoderma* ([@b26-mmr-15-01-0111]--[@b28-mmr-15-01-0111]). Photoaging refers to accelerated aging of the skin induced by UV light exposure, usually with the involvement of ROS ([@b6-mmr-15-01-0111]). It was therefore hypothesized that the anti-aging effects of GL-PS may derive from inhibition of ROS production; however, to the best of our knowledge, no previous studies had investigated the effects of GL-PS on UVB-induced photoaging. Therefore, in the present study, the protective effect of GL-PS on UVB-induced fibroblast aging was examined.

A UVB toxicity study on fibroblasts revealed that fibroblast cell viability decreased dose-dependently as the UVB dose increased; 60 mJ/cm^2^ UVB was the lowest dose resulting in significantly decreased cell viability, so was selected to create the photoaging fibroblast model. The effect of GL-PS on cell viability was subsequently explored. Treatment of cells that had not been exposed to UVB with 20, 40 and 80 µg/ml GL-PS was demonstrated to promote fibroblast cell viability in excess of untreated cells. Treatment of cells exposed to UVB with 10, 20 and 40 µg/ml GL-PS also increased cell viability in excess of UVB exposed cells. GL-PS was reported to prevent apoptosis of pancreatic β-cells ([@b36-mmr-15-01-0111]). Thus, the ability to inhibit apoptosis of GL-PS may be the possible reason for the increased the cell viability of GL-PS treated fibroblasts. Furthermore, 40 µg/ml GL-PS treatment also significantly decreased the percentage of aged cells, suggesting that GL-PS protects fibroblasts from photoaging.

Photoaging includes epidermal photoaging and dermal photoaging, with dermal photoaging more important to the overall photoaging process ([@b2-mmr-15-01-0111]). Skin wrinkles, induced by decreased extra-cellular matrix components, such as collagens, are a major product of photoaging ([@b37-mmr-15-01-0111]). Collagens are primarily produced by fibroblasts and are a major component of the extra-cellular matrix ([@b16-mmr-15-01-0111]). Previous studies have demonstrated that type I collagen, the most abundant collagen, is degraded by MMP-1 ([@b14-mmr-15-01-0111],[@b16-mmr-15-01-0111],[@b38-mmr-15-01-0111]). When degradation of normal collagen and accumulation of abnormal collagen fiber fragments increases, the proliferation of fibroblasts is inhibited, resulting in decreased collagen synthesis ([@b15-mmr-15-01-0111],[@b16-mmr-15-01-0111]). UVB exposure results in upregulated MMP-1 protein expression and decreased collagen expression ([@b19-mmr-15-01-0111]), which the present study also confirmed. In addition, the present study demonstrated the ability of GL-PS to inhibit UVB-induced MMP-1 protein expression and promote CICP protein expression in fibroblasts. Therefore, GL-PS may be involved in the inhibition of extra-cellular matrix degradation, resulting in protection of skin against photoaging.

Major mechanisms of photoaging include UV-associated DNA damage, and UV-induced increases in cellular ROS. Intracellular chromophores absorb UVB energy and interact with oxygen molecules to produce ROS, resulting in induction of the oxidative stress response and subsequent damage to cells ([@b7-mmr-15-01-0111]--[@b9-mmr-15-01-0111]). Zhao *et al* ([@b29-mmr-15-01-0111]) demonstrated that GL-PS treatment protects murine skeletal muscles from exhaustive-exercise-induced oxidative stress. In addition, Kao *et al* ([@b39-mmr-15-01-0111]) isolated low molecular weight β-1,3-glucan from *Ganoderma* and demonstrated that this reduces H~2~O~2~-induced intracellular ROS production, and so inhibits inflammation-induced oxidative stress. In the present study, ROS levels were demonstrated to increase significantly in photoaging fibroblasts and, for the first time, GL-PS treatment was demonstrated to inhibit ROS production following UVB treatment.

During the photoaging process, increased ROS levels also activate growth cytokines and their receptors in fibroblasts and keratinocytes, leading to activation of ERK, p38, and JNK in the MAPK pathway ([@b29-mmr-15-01-0111],[@b40-mmr-15-01-0111]). This promotes MMP expression and decreases collagen levels ([@b10-mmr-15-01-0111],[@b11-mmr-15-01-0111]). The results of the present study demonstrate the antiphotoaging effect of GL-PS *in vitro*, however, the effects of GL-PS on the MAPK and other signaling pathways were not investigated. In addition, the efficacy of GL-PS on photoaging *in vivo* remain to be elucidated. Further studies are required to verify the results of the present study and to assess the underlying mechanism of GL-PS on photoaging.

In conclusion, the present study demonstrates that GL-PS protects fibroblasts from photoaging via its antioxidant ability. This indicates GL-PS treatment may serve as a novel strategy for anti-photoaging.
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![Cell viability of fibroblasts decreases as UVB exposure increases. (A) Cellular density and morphology were observed under a light microscope 48 h subsequent to UVB exposure. (B) Fibroblast cell viability was measured by MTT assay. \*\*P\<0.01 vs. non-exposed control. Data are presented as the mean + standard deviation. UVB, ultraviolet B.](MMR-15-01-0111-g00){#f1-mmr-15-01-0111}

![GL-PS protects fibroblasts against UVB-induced cell death. (A) Cell viability following GL-PS treatment was assessed by MTT assay. \*\*P\<0.01 vs. GL-PS untreated control. (B) Cell viability following exposure to 60 mJ/cm^2^ UVB, then 24 h treatment with GL-PS, was assessed by MTT assay. ^\#^P\<0.05 vs. UVB non-exposed/GL-PS untreated control. \*\*P\<0.01 vs. GL-PS untreated control. Data are presented as the mean + standard deviation. GL-PS, *Ganoderma lucidum* polysaccharides; UVB, ultraviolet B.](MMR-15-01-0111-g01){#f2-mmr-15-01-0111}

![GL-PS inhibits UVB-induced aging in fibroblasts. (A) Representative images of aged cells displaying peri-nuclear blue staining, detected by senescence-associated β-galactosidase staining. (B) Percentage of aged cells. Data are presented as the mean + standard deviation. ^\#^P\<0.05 vs. UVB non-exposed/GL-PS untreated cells. \*P\<0.05 vs. UVB exposed/GL-PS untreated cells. GL-PS, *Ganoderma lucidum* polysaccharides; UVB, ultraviolet B.](MMR-15-01-0111-g02){#f3-mmr-15-01-0111}

![GL-PS inhibits MMP-1 protein expression and increases CICP protein expression in UVB-exposed fibroblasts. (A) MMP-1 and (B) CICP protein expression levels measured by ELISA. Data are presented as the mean + standard deviation. ^\#^P\<0.05, ^\#\#^P\<0.01 vs. UVB non-exposed/GL-PS untreated cells; \*\*P\<0.01 vs. UVB exposed/GL-PS untreated cells. GL-PS, *Ganoderma lucidum* polysaccharides; MMP-1, matrix metalloproteinase 1; CICP, C-telopeptide of Type I collagen; UVB, ultraviolet B.](MMR-15-01-0111-g03){#f4-mmr-15-01-0111}

![GL-PS inhibits the UVB-induced increase in ROS in fibroblasts. Fluorescence staining and flow cytometry were used to measure ROS levels. (A) Fluorescent staining of ROS-positive cells. (B) Quantitation of ROS levels. Data are presented as the mean + standard deviation. \*P\<0.01 vs. UVB non-exposed/GL-PS untreated cells. \*P\<0.05 vs. UVB exposed/GL-PS untreated cells. GL-PS, *Ganoderma lucidum* polysaccharides; UVB, ultraviolet B; ROS, reactive oxygen species.](MMR-15-01-0111-g04){#f5-mmr-15-01-0111}

[^1]: Contributed equally
